MENU
+Compare
MFDX
ETF ticker: NYSE ARCA
AS OF
Jan 17 closing price
Price
$29.83
Change
+$0.11 (+0.37%)
Net Assets
267.6M

MFDX stock forecast, quote, news & analysis

MFDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for MFDX with price predictions
Jan 08, 2025

MFDX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MFDX turned positive on January 06, 2025. Looking at past instances where MFDX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MFDX's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on MFDX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MFDX advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where MFDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for MFDX moved below the 200-day moving average on January 07, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), BHP Group Limited (NYSE:BHP), Boeing Company (NYSE:BA), AT&T (NYSE:T), Medtronic plc (NYSE:MDT), BP plc (NYSE:BP), Shopify (NYSE:SHOP), Canadian Natural Resources Limited (NYSE:CNQ), Allergan plc (NYSE:AGN).

Industry description

The investment seeks to track the investment results of the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The fund seeks to achieve its investment objective by investing at least 80% of its total assets (exclusive of collateral held from securities lending) in the component securities of the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The underlying index is constructed by the index provider using a rules-based approach to construct factor portfolios within the underlying index. The underlying index consists of "factor portfolios," each of which emphasizes one of the following factors: value, low volatility, quality, momentum and size.

Market Cap

The average market capitalization across the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF is 29.23B. The market cap for tickers in the group ranges from 989.57K to 380.18B. ASML holds the highest valuation in this group at 380.18B. The lowest valued company is ANDR at 989.57K.

High and low price notable news

The average weekly price growth across all stocks in the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF was 2%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was -1%. AGL experienced the highest price growth at 27%, while SALM experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF was -15%. For the same stocks of the ETF, the average monthly volume growth was -18% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 51
Price Growth Rating: 52
SMR Rating: 65
Profit Risk Rating: 57
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
MFDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Fundamentals
Details
Category
Foreign Large Blend
Address
PIMCO Equity Series650 Newport Center DriveNewport Beach
Phone
N/A
Web
www.pimco.com